NCT01056575View on ClinicalTrials.gov

Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions

Healthy Volunteers

Interventions

DRUG

OC000459

OC000459 100mg tablet, twice daily

Trial Locations (1)

CF48 4DR

Simbec Research Ltd, Merthyr Tydfil

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Oxagen Ltd

INDUSTRY